Global Cat Allergy Therapeutics Market: Overview

Cat allergy is an allergic reaction in humans to the allergens produced by cats. The most common cat allergen types are Fel d1 (secreted by cat’s sebaceous glands) and Fel d4 (found in cat’s saliva). Nearly 25% of allergic patients tend to suffer from cat allergy due to Fel d1 and Fel d4. Cat allergens are produced in large amounts, especially Fel d1, in the form of dander and is considered to be a major reason of causing allergic asthma across the world. Avoiding cats is the primary therapy for allergic patients. However, certain allergy drugs and allergy shots help to control the symptoms of cat allergy.

Global Cat Allergy Therapeutics Market: Key Trends

Increase in the number of patients with cat allergy, rise in the trend of having cat as pet animal, and surge in awareness about available treatment options are projected to drive the global cat allergy therapeutics market during the forecast period. Moreover, rise in cases of allergic rhinitis and allergic asthma due to cat allergy are anticipated to augment the global market. Increase in health care expenditure by governments and initiatives to spread awareness about the treatment are also expected to propel the global cat allergy therapeutics market. Increase in investment in research & development especially in immunotherapy treatment is likely to boost the growth of the global cat allergy therapeutics market. For instance, as per journal published by AAIR (Allergy, Asthma Immunology Research), in 2018, expenditure on allergic rhinitis is estimated at EUR 2.7 Bn per year. It is the most expensive disease in the U.S., costing around US$ 593 per employee/year. Moreover, increase in the sensitized population across the world and rise in ownership of domestic animals are anticipated to propel the global cat allergy therapeutics market during the forecast period. However, unmet needs in the diagnosis and treatment of animal (cat) allergies, inappropriate medical management, and stringent guidelines are likely to restrain the global cat allergy therapeutics market during the forecast period.

Global Cat Allergy Therapeutics Market: Segmentation

The global cat allergy therapeutics market can be segmented based of treatment, route of administration, end-user, and region. In terms of treatment, the market can be classified into antihistamines, decongestants, corticosteroids, immunotherapy, and others. Antihistamine includes cetirizine, diphenhydramine, and fexofenadine. Based on route of administration, the global cat allergy therapeutics market can be categorized into oral, nasal, and subcutaneous. In terms of distribution channel, the market can be divided into hospital pharmacies, retail pharmacies, and online pharmacies.

Global Cat Allergy Therapeutics Market: Geographical Distribution

In terms of region, the global cat allergy therapeutics market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global market in 2017 and the trend is projected to continue during the forecast period. This is attributed to rise in prevalence of cat allergies in people, increase in awareness about cat allergy symptoms, surge in health care expenditure, and rise in demand for diagnostic kits used to detect cat allergy. According to the American Pet Products Association, in 2017, there are 85.8 million pet cats worldwide; and in the U.S. there were 42.9 million cats (35% households happen to have these pet cats). Rise in prevalence of allergic diseases such as allergic rhinoconjunctivitis and allergic asthma due to cat allergy is anticipated to augment the global cat allergy therapeutics market. The market in Europe and Asia Pacific is expected to grow at a rapid pace during the forecast period. Increasing sensitization due to the allergen of the domestic animals are likely to drive the market in these regions during the forecast period. For instance, sensitization in cats is 12.2% and 30.8% to cat hair in China. Sensitization to cat hair is 8.1% in developing regions and 8.7% in the developed regions. According to a journal published by Allergy, Asthma & Immunology Research (2018), 22% of the households in South Korea had a pet in 2016. These factors are expected to drive the market in Asia Pacific during the forecast period.

Global Cat Allergy Therapeutics Market: Competitive Landscape

Major players operating in the global cat allergy therapeutics market include Bristol-Myers Squibb Company, GlaxoSmithKline plc, Merck & Co., Inc., Aventis Pharmaceutical, Pharmacia Upjohn, and others. Companies that have cat allergy therapeutic products in pipeline are Sementis and Circassia.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.


Cat Allergy Therapeutics Market

Pre Book